nipocalimab

1 Drug classified under this active ingredient

Monoclonal Antibody, Neonatal Fc Receptor Antagonist (FcRn). nipocalimab 185 mg.
VIAL.Conc. for sol. for inf. 1 x 1.62 /6.5 ml.
Initial dosage is 30 mg/kg admin. once via IV. After 2 weeks, admin a maint. dosage of 15 mg/kg. Continue maint. dosage every two weeks thereafter.
Tmt. of gralized myasthenia gravis (gMG) in adult and ped. pts  >12 years who are anti-acetylcholine recept. (AChR) or antimuscle- specific tyrosine kinase (MuSK) antibody pos.
C/I: Hypersens. Reactions have incl. anaphylaxis and angioedema.